Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Bosentan on Testicular Function in Male PAH Patients
NCT00082186Phase 4Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Jul 2003
- Primary completion
- Feb 2007
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
01
Overview
A Phase 4 trial of bosentan in pulmonary arterial hypertension (PAH), sponsored by Actelion Pharmaceuticals Ltd. Started Jul 2003; status: completed.
02
Drugs
bosentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00082186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082186.